Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Aptevo Therapeutics Inc. logo

Aptevo Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

Optionable: No  Market Cap: 12 M  90-day average vol: 52,954

Previous close: 1.58  Open: 1.57  Bid: 1.58  Ask: 1.66
52 week range    
Last updated: Thursday 8th June 2023
MarketXLS Rank

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


APVO Income Statement

Invalid dateDec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles-800000.0-800000.00.00.0
Basic EPS from continuing operations1.37
Basic EPS total1.57
Basic weighted shares outstanding1 M2 M2 M208359.03 M5 M5 M
Cost of sales-12 M-5 M-11 M-20 M
Depreciation-1 M-1 M-2 M-1 M-1 M-1 M-900000.0
DepreciationAndAmortization-1 M-1 M-2 M-1 M-1 M-1 M-900000.0
Diluted EPS total5.1826.04-33.4612.63.880.21.57
Diluted normalized net income/share1.37
Diluted weighted shares outstanding5 M
GainOnSaleOfBusiness14 M
GainOnSaleOfSecurity53 M4 M14 M
GainsLossOnDisposalOfDiscontinuedOperations7 M40 M3 M13 M951000.01 M
GeneralAndAdministrativeExpense-2 M-2 M-1 M16 M14 M15 M14 M
Gross operating profit-2 M10 M12 M12 M4 M12 M3 M
ImpairmentOfCapitalAssets71 M
Income before tax-140 M-56 M-54 M-41 M-31 M-29 M7 M
Income taxes-20 M-23 M
MiscOtherSpecialCharges-810000.0-2 M-2 M-2 M-3 M-8 M33 M
Net income from total operations-112 M7 M-54 M-40 M-18 M-28 M8 M
NetIncomeCommonStockholders-112 M7 M-54 M-40 M-18 M-28 M8 M
NetIncomeContinuousOperations-112 M7 M-54 M-40 M-18 M-28 M8 M
NetIncomeDiscontinuousOperations7 M40 M3 M13 M951000.01 M
NetIncomeFromOtherGainsLosses-2 M-1 M
Operating income-68 M-54 M-52 M-41 M-27 M-21 M-29 M
Operating income before depreciation (EBITDA)-136 M-53 M-51 M-39 M-30 M-28 M8 M
OperatingExpense65 M64 M64 M41 M32 M34 M32 M
OperatingRevenue10 M15 M23 M0.04 M12 M3 M
Other income net810000.02 M2 M-4 M3 M8 M-33 M
Other special charges-2 M
OtherGandA-2 M-2 M-1 M16 M14 M15 M14 M
OtherOperatingExpenses-2 M-2 M-2 M-1 M
RentAndLandingFees-2 M-2 M0.016 M14 M15 M14 M
Research & development expense29 M29 M35 M25 M18 M19 M18 M
ResearchExpense29 M29 M35 M25 M18 M19 M18 M
SalariesAndWages-4 M-5 M-2 M-2 M-1 M-2 M-2 M
Selling Gen & administrative expense36 M35 M28 M16 M14 M15 M14 M
SellingAndMarketingExpense36 M35 M28 M25 M
SellingExpense36 M35 M28 M25 M
Special income/charges-71 M3 M
Total Income available for interest expense (EBIT)-140 M-56 M-54 M-41 M-31 M-29 M7 M
Total common shares outstanding1 M2 M3 M3 M4 M5 M7 M
Total net income-112 M7 M-54 M-40 M-18 M-28 M8 M
Total ordinary shares7 M7 M7 M7 M7 M7 M7 M
Total revenues10 M15 M23 M32 M4 M12 M3 M
TotalExpenses53 M59 M52 M41 M32 M34 M32 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and starter sheets.
Get started today